Business Services Industry
Kemira Oyj completes acquisition of Arkema's coagulant business for water treatment
Nordic Business Report, Dec 3, 2007
NORDIC BUSINESS REPORT-3 December 2007-Kemira Oyj completes acquisition of Arkema's coagulant business for water treatment(C)1994-2007 M2 COMMUNICATIONS LTD http://www.m2.com
Finnish chemicals group Kemira Oyj said on Monday (3 December) that the transaction by which Kemira Chimie S.A. in France and Kemira Iberica SA in Spain acquire Arkema's coagulant business for water treatment has concluded.
Kemira said that with the acquisition Kemira Water improves its market position for coagulants in France and Spain.
The acquired Arkema's coagulant business includes three production units located in France and Spain. The main customer base is municipalities for potable and wastewater treatment.
In 2006, the revenue of Arkema's coagulants business for water treatment totalled approximately EUR19m.
Kemira Oyj, headquartered in Helsinki, Finland, is a chemicals group that operates in 40 countries. In 2006 Kemira recorded revenue of EUR2.52bn and it has some 8,000 employees. The company is listed on the OMX Nordic Exchange in Helsinki.
One British pound (GBP) is worth approximately 1.40 euros (EUR).
((Comments on this story may be sent to nbr.feedback@nordicbusinessreport.com))
- 5 Rules for Immediate Annuities
- Death in the Family: 12 Things to Do Now
- Dumbest Things You Do With Your Money
- 6 Online Networking Mistakes to Avoid
- 401(k) Mistakes to Avoid
- 5 Economic Scenarios to Keep You Up at Night
- The Real ‘Best Places to Retire’
- Best Credit Cards for You
- 12 Tough Questions to Ask Your Parents
- The Real ‘Best Colleges’
- Home Buyer Tax Credit: How to Cash In
- Why You Shouldn't Bash Cash
- 8 Phony 'Bargains' and Better Alternatives
- Danger: 3 Debit Card Scams to Avoid
- 6 Myths About Gas Mileage
- 29 Fees We Hate Most
- Quick and Easy Ways to Boost Returns
- Best Stocks to Buy Now
- Lower Your Taxes: 10 Moves to Make Now
- New Jobs: 8 Lessons from Real-Life Career Switchers
- The New Job Market: Who Wins and Who Loses?
- Health Care Reform's Public Option: Everything You Need to Know
- Volunteer Work When Unemployed: Should You Work for Free?
- Whose Recovery Is This?
- Long-Term-Care Insurance: 4 Biggest Risks to Avoid
Most Recent Business Articles
- Psyadon Pharmaceuticals, Inc. Announces Regulatory Milestones and the Initiation of a Clinical Trial of Ecopipam in Lesch-Nyhan Disease
- Emergence of “Femtomedicine” - New Frontier of Biomed Sciences - Reported at First Global Congress on Nano Medicine
- Research and Markets: Ethiopia Power Market Outlook to 2020
- Research and Markets: Orphan Drugs in Asia-Pacific: from Designation to Pricing, Funding & Market Access
- Research and Markets: Now You See It - TV Program Sponsorship & Product Placement in China
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FHM Features Anna Benson, Baseball's Hottest Wife
- Building a DNA database: the federal government has just enacted two bills related to DNA. The first would drive the collection of DNA from all infants. The second would attempt to prevent the DNA that is collected from being misused
- America's most wanted j-o-b-s - 10 hottest employment opportunities
- Developmental sequence in small groups


